Comparisons and combinations in anti-anginal therapy.
The availability of three distinct classes of anti-anginal agents makes it possible, in theory, to choose a single drug to counteract the specific mechanism responsible for the syndrome in an individual patient, or to combine therapy where appropriate. In practice, other factors, such as concomitant disease, cost and side-effects, prove to have an over-riding influence on the choice of treatment which, in any case, often has to be decided upon on the basis of trial and error.
Julian
D G
DG
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D003326:Coronary Circulation / Q000187:drug effects; D004359:Drug Therapy, Combination; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D009566:Nitrates